Stay updated on IMMUTACE Clinical Trial
Sign up to get notified when there's something new on the IMMUTACE Clinical Trial page.

Latest updates to the IMMUTACE Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has undergone significant changes, including the removal of detailed information about the IMMUTACE study and its findings related to the treatment of hepatocellular carcinoma. Additionally, new references to collaborators and study identifiers have been added.SummaryDifference48%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to IMMUTACE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMMUTACE Clinical Trial page.